Skip to main content
Equibles

NewEdge Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1633516 NEW ORLEANS, LA
Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$55,891,426
+$1,197,761 QoQ
Shares Held
442,389
+12.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#197
of 2,284 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $832,318,596 across 17 Drug Manufacturers - General names. GILD ranks #5 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 194,721 $233,554,228
2 JNJ
Johnson & Johnson
 917,872 $233,111,951
3 ABBV
AbbVie Inc.
 439,164 $110,511,228
4 MRK
Merck & Co., Inc.
 455,515 $58,533,677
5 GILD
Gilead Sciences, Inc.
This page 		442,389 $55,891,426
6 GSK
GSK plc
 953,574 $49,986,349
7 AMGN
Amgen Inc
 93,040 $33,691,644
8 PFE
Pfizer Inc
 687,769 $16,561,477

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,891,426 442,389
2026-03-31 $54,693,665 392,435
2025-12-31 $19,726,772 160,720
2025-09-30 $17,658,213 159,083
2025-06-30 $11,806,435 106,489
2025-03-31 $10,598,361 94,586
2024-12-31 $8,465,987 91,653
2024-09-30 $4,694,704 55,996
2024-06-30 $3,781,645 55,118
2024-03-31 $4,426,131 60,425
2023-12-31 $4,979,117 61,463
2023-09-30 $4,438,546 59,228
2023-06-30 $4,853,637 62,977
2023-03-31 $3,976,586 47,928
2022-12-31 $3,208,557 37,374
2022-09-30 $1,839,719 29,822
2022-06-30 $1,704,410 27,575
2022-03-31 $1,520,433 25,575
2021-12-31 $2,260,131 31,127
2021-09-30 $950,728 13,611
2021-06-30 $1,240,030 18,008
2021-03-31 $1,254,726 19,414
2020-12-31 $1,718,145 29,491
2020-09-30 $1,945,430 30,787
2020-06-30 $2,088,536 27,145
2020-03-31 $2,321,597 31,054